Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-09

Clinical Trial Update: Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether combining multi-zonal contact lenses with atropine can reduce progression of myopia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine (atropine)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Myopia | Phase 2 | Status: NOT_YET_RECRUITING